Humulin®

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

CONNECTED CARE: Current Platforms in Development

Connected care is currently developing 2 platforms.

Detailed Information

Connected Care is Lilly’s holistic solution that will include both a pen- and pump-based platform to provide the DM community with insights that can help with management of the condition.

Connected Care Pump-Based Platform

Lilly's Connected Care pump-based platform is a hybrid closed-loop system designed to adjust basal insulin infusion rates to maintain BG levels within a specified target range via

  • insulin pump with a dedicated controller

  • dosing algorithm, and

  • CGM.

Connected Care Pen-Based Platform

Lilly's Connected Care pen-based platform would deliver personalized insulin dose recommendation via the

  • Connected Care pen

  • glucose-sensing technologies (eg, BGM, CGM), and 

  • the mobile app.

The mobile app will provide personalized insulin dose recommendations. The mobile app will collect, store, and review

  • glucose data (via a compatible bluetooth-enabled BGM, or Dexcom CGM)

  • insulin dose data (via an attachment for the Connected Care pen)

  • meal details, and

  • other health-related information.

This data will be used to electronically log and remind users of insulin dosing.

Glossary

BG = blood glucose

BGM = blood glucose monitor

CGM = continuous glucose monitoring

DM = diabetes mellitus

Lilly = Eli Lilly and Company

T1DM = type 1 diabetes mellitus

T2DM = type 2 diabetes mellitus

Date of Last Review: November 22, 2019

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical